VA
VR Adviser’s Terns Pharmaceuticals TERN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,077,090
| Closed | -$5.97M | – | 40 |
|
|
2024
Q4 | $5.97M | Sell |
1,077,090
-2,332,968
| -68% | -$12.9M | 0.41% | 28 |
|
|
2024
Q3 | $28.4M | Hold |
3,410,058
| – | – | 1.49% | 19 |
|
|
2024
Q2 | $23.2M | Hold |
3,410,058
| – | – | 1.48% | 21 |
|
|
2024
Q1 | $22.4M | Sell |
3,410,058
-1,087,059
| -24% | -$7.13M | 1.06% | 25 |
|
|
2023
Q4 | $29.2M | Buy |
4,497,117
+1,404,844
| +45% | +$9.12M | 2% | 14 |
|
|
2023
Q3 | $15.6M | Buy |
3,092,273
+119,404
| +4% | +$601K | 1.64% | 20 |
|
|
2023
Q2 | $26M | Sell |
2,972,869
-646,653
| -18% | -$5.66M | 4.16% | 9 |
|
|
2023
Q1 | $42.9M | Sell |
3,619,522
-88,369
| -2% | -$1.05M | 8.37% | 4 |
|
|
2022
Q4 | $37.7M | Hold |
3,707,891
| – | – | 6.36% | 5 |
|
|
2022
Q3 | $21.8M | Buy |
+3,707,891
| New | +$21.8M | 3.37% | 9 |
|